文献速递系统性红斑狼疮

循环脂联素水平与系统性红斑狼疮:两样本孟德尔随机化研究

Circulating adiponectin levels and systemic lupus erythematosus: a two-sample Mendelian randomization study.
PubMed 文献 · Rheumatology (Oxford) · 2021-01-01

逆方差加权法显示遗传预测的循环脂联素水平与SLE风险无显著因果关联(OR 1.38,95%CI 0.91–1.35,P=0.130),其他MR方法结果一致。反向MR分析也未发现SLE遗传风险对循环脂联素水平的因果效应。

要点

  • 遗传预测的循环脂联素水平与SLE风险无显著因果关联。
  • 多种MR方法(IVW、MR-Egger、加权中位数、加权模式)结果一致。
  • 反向MR分析未发现SLE遗传风险影响循环脂联素水平。

核心结论

  • 未发现循环脂联素水平与SLE风险之间存在因果关系的证据,也未发现SLE对循环脂联素水平有因果效应的证据。

研究设计与样本

  • 两样本孟德尔随机化研究,从已发表的全基因组关联研究荟萃分析中选取9个与循环脂联素水平相关的独立单核苷酸多态性作为工具变量。
  • 采用逆方差加权法、MR-Egger回归、加权中位数法和加权模式法评估因果效应。

主要发现

  • 逆方差加权法显示遗传预测的循环脂联素水平与SLE风险无显著因果关联,OR为1.38(95%CI 0.91,1.35;P=0.130)。
  • MR-Egger法OR为1.62(95%CI 0.85,1.54),P=0.195。
  • 加权中位数法OR为1.37(95%CI 0.82,1.35),P=0.235。
  • 加权模式法OR为1.39(95%CI 0.86,1.38),P=0.219。
  • 以SLE相关单核苷酸多态性为工具变量的MR分析显示,遗传预测的SLE风险与循环脂联素水平无关联。

临床怎么用

  • 本研究结果不支持将循环脂联素水平作为SLE风险评估或干预的因果靶点。
  • 观察性研究中报道的脂联素与SLE关联可能并非因果关系,临床解读时需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Several studies have reported increased serum/plasma adiponectin levels in SLE patients. This study was performed to estimate the causal effects of circulating adiponectin levels on SLE. METHODS: We selected nine independent single-nucleotide polymorphisms that were associated with circulating adiponectin levels (P < 5 × 10-8) as instrumental variables from a published genome-wide association study (GWAS) meta-analysis. The corresponding effects between instrumental variables and outcome (SLE) were obtained from an SLE GWAS analysis, including 7219 cases with 15 991 controls of European ancestry. Two-sample Mendelian randomization (MR) analyses with inverse-variance weighted, MR-Egger regression, weighted median and weight mode methods were used to evaluate the causal effects. RESULTS: The results of inverse-variance weighted methods showed no significantly causal associations of genetically predicted circulating adiponectin levels and the risk for SLE, with an odds ratio (OR) of 1.38 (95% CI 0.91, 1.35; P = 0.130). MR-Egger [OR 1.62 (95% CI 0.85, 1.54), P = 0.195], weighted median [OR 1.37 (95% CI 0.82, 1.35), P = 0.235) and weighted mode methods [OR 1.39 (95% CI 0.86, 1.38), P = 0.219] also supported no significant associations of circulating adiponectin levels and the risk for SLE. Furthermore, MR analyses in using SLE-associated single-nucleotide polymorphisms as an instrumental variable showed no associations of genetically predicted risk of SLE with circulating adiponectin levels. CONCLUSION: Our study did not find evidence for a causal relationship between circulating adiponectin levels and the risk of SLE or of a causal effect of SLE on circulating adiponectin levels.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Dan YL, Wang P, Cheng Z, et al. Circulating adiponectin levels and systemic lupus erythematosus: a two-sample Mendelian randomization study. Rheumatology (Oxford). 2021. PMID: 32944772. doi:10.1093/rheumatology/keaa506

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。